The Capital Markets Day took place on 12 June 2018 at the Four Seasons Hotel at Ten Trinity Square in London, UK. The various presentations are available in the agenda column. We will be publishing videos of the presentations in a short while.
Hearing healthcare strategy update
Innovation as a competitive advantage
Operational excellence in retail
Opening up the world of sound with hearing implants
Financial update and status on strategic initiatives
Hearing aid user
Interview with participants
6 November 2018 – Interim Management Statement
Please go to Calendar & Presentations, if you wish to see the latest IR presentation
Download and browse reports, presentations and documents within the areas Annual General Meeting, Investor Relations, Responsibility, Corporate Governance and Business policies.
2017: DKK 13,189 million
2016: DKK 12,002 million
2017: DKK 2,504 million
2016: DKK 2,130 million
latest annual report
The William Demant Group is one of the world’s leading hearing healthcare companies. We are in the business of making a life-changing difference for millions of people across the world.
We are the only company in the world that covers all the four business activities of the hearing healthcare area, i.e. traditional hearing instruments, hearing implants, diagnostic instruments as well as personal communication.
With our approach to hearing healthcare and our complete product range, we are fully equipped to help people with various kinds of hearing loss connect with the world and live their lives to the fullest.
The William Demant Group is one of the world’s leading hearing healthcare companies making a life-changing difference to millions of people all over the world.
Find presentations from events such as Interim Reports and Information, Capital Markets Days and Annual General Meetings.
With a unique position in the hearing healthcare market, based on true innovation and an efficient global set-up, we are equipped to help millions of people.
Listed on Nasdaq Copenhagen as part of the 25 largest shares in terms of free floated market capitalisation, the C25 index, William Demant is a leading global company that develops, manufactures and sells hearing instruments, hearing implants, diagnostic instruments and personal communication devices. William Demant Invest, wholly owned by the Oticon Foundation, holds the majority of shares in William Demant Holding, the company behind the commercial successes of such world-renowned brands as Oticon, Bernafon, Sonic, Oticon Medical, Maico, Interacoustics, Grason-Stadler and Sennheiser Communications.
The Group operates in a global market with companies in more than 30 countries, has a total staff exceeding 13,000 and generates annual revenues of more than DKK 13 billion. Our products are sold in more than 130 countries.